Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Corneal neovascularization (CNV) has a variety of causes and threatens corneal clarity, thus optimal visual acuity.Conventional medical management includes topical steroids and matrix metalloproteinase inhibitors like doxycycline.Anti-vascular endothelial growth factor (anti-VEGF) agents have demonstrated promise but remain off-label for this indic